246 related articles for article (PubMed ID: 10869530)
1. Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats.
Bishop JE; Kiernan LA; Montgomery HE; Gohlke P; McEwan JR
Cardiovasc Res; 2000 Jul; 47(1):57-67. PubMed ID: 10869530
[TBL] [Abstract][Full Text] [Related]
2. Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats.
Zolk O; Quattek J; Seeland U; El-Armouche A; Eschenhagen T; Böhm M
Cardiovasc Res; 2002 Feb; 53(2):363-71. PubMed ID: 11827687
[TBL] [Abstract][Full Text] [Related]
3. [Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats].
Grima M; Anjuère J; Ingert C; Coquard C; Steger J; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):805-12. PubMed ID: 11575208
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
[TBL] [Abstract][Full Text] [Related]
5. Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways.
Witte K; Huser L; Knotter B; Heckmann M; Schiffer S; Lemmer B
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):101-9. PubMed ID: 11191827
[TBL] [Abstract][Full Text] [Related]
6. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.
Linz W; Schaper J; Wiemer G; Albus U; Schölkens BA
Br J Pharmacol; 1992 Dec; 107(4):970-5. PubMed ID: 1334756
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 gene.
Rothermund L; Pinto YM; Vetter R; Herfort N; Kossmehl P; Neumayer HH; Paul M; Kreutz R
J Hypertens; 2001 Aug; 19(8):1465-72. PubMed ID: 11518855
[TBL] [Abstract][Full Text] [Related]
8. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production.
Ogawa T; Linz W; Stevenson M; Bruneau BG; Kuroski de Bold ML; Chen JH; Eid H; Schölkens BA; de Bold AJ
Circulation; 1996 Jun; 93(11):2059-67. PubMed ID: 8640983
[TBL] [Abstract][Full Text] [Related]
9. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats.
Ohta K; Kim S; Wanibuchi H; Ganten D; Iwao H
Circulation; 1996 Aug; 94(4):785-91. PubMed ID: 8772703
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27.
Montgomery HE; Kiernan LA; Whitworth CE; Fleming S; Unger T; Gohlke P; Mullins JJ; McEwan JR
J Hypertens; 1998 May; 16(5):635-43. PubMed ID: 9797175
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.
Linz W; Wiemer G; Schaper J; Zimmermann R; Nagasawa K; Gohlke P; Unger T; Schölkens BA
Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):89-97. PubMed ID: 7494560
[TBL] [Abstract][Full Text] [Related]
12. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
Brilla CG; Rupp H; Maisch B
Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
[TBL] [Abstract][Full Text] [Related]
13. Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
Rossi GP; Cavallin M; Rizzoni D; Bova S; Mazzocchi G; Agabiti-Rosei E; Nussdorfer GG; Pessina AC
J Hypertens; 2002 Jul; 20(7):1451-9. PubMed ID: 12131544
[TBL] [Abstract][Full Text] [Related]
14. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition.
Grimm D; Kromer EP; Böcker W; Bruckschlegel G; Holmer SR; Riegger GA; Schunkert H
J Hypertens; 1998 Sep; 16(9):1345-55. PubMed ID: 9746122
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
[TBL] [Abstract][Full Text] [Related]
16. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
Seeland U; Kouchi I; Zolk O; Jockenhövel F; Itter G; Linz W; Böhm M
Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820
[TBL] [Abstract][Full Text] [Related]
17. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
Zhu YC; Zhu YZ; Gohlke P; Stauss HM; Unger T
Am J Cardiol; 1997 Aug; 80(3A):110A-117A. PubMed ID: 9293963
[TBL] [Abstract][Full Text] [Related]
19. The effect of non-antihypertensive doses of angiotensin converting enzyme inhibitor on myocardial necrosis and hypertrophy in young rats with renovascular hypertension.
Matsubara BB; Matsubara LS; Franco M; Padovani JC; Janicki JS
Int J Exp Pathol; 1999 Apr; 80(2):97-104. PubMed ID: 10469264
[TBL] [Abstract][Full Text] [Related]
20. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
